Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,643 results that match your search.22,643 results
  • In a much-awaited decision and probably the first of its kind in India, in the case of Natco v Bayer, the Office of the Controller General of the Indian Patent Office issued a compulsory licence in favour on Natco. Natco now has a non-exclusive and non-assignable licence to Bayer's Indian Patent 215758, for making, using, selling and offering to sell (not importing) the generic version of Nexavar (sorafenib tosylate) within India, for the treatment of kidney and liver cancer. Interestingly, the entire proceeding lasted less than a year and the drug in question was not a life-saving drug.
  • Last January 27, the Industrial Property Law was amended, with the most relevant issues relating to enforcement of IP rights entering in force on January 30.
  • The district court in summary proceedings recently rejected Taste of Nature's bid to ban infringement of its European Raphanus patent. The court held that there is a significant chance that the patent will be revoked, because it relates to subject matter which is excluded from patentability.
  • In 2006 the New Zealand Domain Name Commission, the body that administers .nz domain names, established a dispute resolution procedure.
  • On September 29 2008, Sanofi Pasteur, the vaccines division of Sanofi-Aventis, filed an opposition against the application by Getz Bros Philippines for the trademark Comaxin, covering pharmaceutical products for the treatment of infections in the upper and lower respiratory tract, ENT, skin and soft tissue, gut infections, osteomylitis, septcoemia, peritonitis and post-op infections in class 5. Sanofi Pasteur claimed that Getz's Comaxin mark was confusingly similar with its own Combaxim mark registered in 2007, covering pharmaceutical preparations in the form of pediatric vaccines.
  • According to the Norwegian domain name policy, only companies registered in the Norwegian Register of Legal Entities may register .no domain names. For foreign companies, the most common solution for fulfilling local presence requirements is to register a Norwegian branch office.
  • A Russian applicant filed a trade mark application on January 18 2010, in Classes 35 and 36, for a blue oval with 10 stars along the periphery and word elements Coast Line (stylised) and Real Estate in European Countries (in Cyrillics).
  • Taiwan Trademark Law has a post-registration opposition system, allowing any third party to file an opposition action against a registered trade mark during the three months after registration. Once the mark is revoked, the mark is deemed not to have been registered ab initio. Also according to the law, the Trademark Office may, ex officio or upon request, cancel a registered trade mark if the mark has not been put to use or its use has discontinued for three years without a justifiable reason.
  • The Cantonal Court of Zug recently rejected a request of a copyright owner for a provisional injunction prohibiting the sale of second-hand software specimens.
  • Thailand follows the first-to-file rule for trade marks. To obtain protection of a mark in Thailand, a registration must be obtained from the Department of Intellectual Property (DIP) initiated by filing an application with the Trademark Office.